This issue indicates the importance of further clinical studies to evaluate the significance of different cancer prevention options among the carriers of specific genetic alterations in BRCA1 and other breast and ovarian cancer susceptibility genes. The gene discussed is BRCA1; the disease is ovarian cancer.